Clinical trial
Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum…
NCT00099359 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00099359 |
|---|---|
| Title | Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission |
| Official title | Phase III Randomized Trial of the Safety and Efficacy of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV-1 Transmission |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Disease Transmission, Vertical, Vertical Human Immunodeficiency Virus Transmission, HIV Infections |
| Intervention type | Drug |
| Interventions | Zidovudine, Nevirapine (NVP), Epivir (3TC), Nelfinavir (NFV) |
| Enrollment | 1,735 |
| Start date | Feb 1, 2004 |
| Primary completion | Feb 1, 2011 |
| Completion | Feb 1, 2011 |
| First posted | Dec 13, 2004 |
| Last update posted | Dec 4, 2012 |
| Countries | Argentina, Brazil, Puerto Rico, South Africa, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: